tiprankstipranks
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
EVFM
Evofem Biosciences
RESEARCH TOOLSreports
Want to see EVFM full AI Analyst Report?

Evofem Biosciences (EVFM) Income Statement

1,206 Followers

Evofem Biosciences Income Statement

Last quarter (Q4 2025), Evofem Biosciences's total revenue was $9.56M, an increase of 34.59% from the same quarter last year. In Q4, Evofem Biosciences's net income was $2.79M. See Evofem Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 20.18M$ 19.36M$ 18.22M$ 16.84M$ 8.24M
Gross Profit
$ 15.07M$ 15.53M$ 11.71M$ 12.42M$ 4.19M
Operating Expenses
$ 13.63M$ 23.20M$ 29.55M$ 96.55M$ 170.99M
Depreciation and Amortization
$ 626.00K$ 756.00K$ 1.78M$ 2.05M$ 1.02M
EBITDA
$ 2.06M$ -6.92M$ -16.07M$ -82.08M$ -165.78M
Operating Income
$ 1.44M$ -7.68M$ -17.85M$ -84.12M$ -166.80M
Other Income/Expenses
$ -1.05M$ -1.18M$ 70.84M$ 7.47M$ -38.37M
Pretax Income
$ 393.00K$ -8.86M$ 53.00M$ -76.65M$ -205.18M
Net Income
$ 391.00K$ -8.86M$ 52.98M$ -76.70M$ -205.19M
Per Share Metrics
Basic EPS
$ <0.01$ -0.09$ 10.36$ -164.59$ -2.96K
Diluted EPS
$ 0.00$ -0.09$ 0.05$ -164.59$ -2.96K
Weighted Average Shares Outstanding
 123.66M 96.46M 4.83M 465.98K 69.82K
Weighted Average Shares Outstanding (Diluted)
 6.42B 96.46M 984.04M 465.98K 69.82K
Currency in USD

Evofem Biosciences Earnings and Revenue History